Phosphoinositide 3 kinase signaling pathway activation has been demonstrated in different types of human cancers, including glioblastoma, because of gain-of-function mutations in PIK3CA or loss of PTEN [99]. The gene discussed is PIK3CA; the disease is glioblastoma.